Effects of acepromazine on equine polymorphonuclear neutrophil activation: A chemiluminescence study

Veterinary Journal

Volumn 157, Issue 3, 1999, Pages 332-335

  Serteyn, D ^a   Benbarek, H ^a   Deby Dupont, G ^a   Grulke, S ^a   Caudron, I ^a   Deby, C ^a   Lamy, M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Acepromazine; Chemiluminescence; Horse; Leukocyte; Reactive oxygen species

Indexed keywords

ACEPROMAZINE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; NEUROLEPTIC AGENT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANESTHESIA; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; HORSE; NEUTROPHIL; NONHUMAN;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0032923269     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1053/tvjl.1998.0308     Document Type: Article

References (24)

1. AKARD L.P., ENGLISH D. & GABIG T.G. (1988). Rapid deactivation of NADPH oxidase in neutrophils: continuous replacement by newly activated enzyme sustains the respiratory burst. Blood 72, 322-7.
2. 2 species in vitro and in rat lungs by chemiluminescence. Journal of Applied Physiology 67, 1912-21.
3. BAXTER G.M., LASKEY R.E., TACKETT R.L., MOORE J.N. & ALLEN D. (1989a). In vitro reactivity of digital arteries and veins to vasoconstrictive mediators in healthy horses and in horses with early laminitis. American Journal of Veterinary Research 50, 508-17.
4. BAXTER G.M., TACKETT R.L. & MOORE J.N. (1989b). Reactivity of equinepalmar digital arteries and veins to vasodilating agents. Veterinary Surgery 18, 221-6.
5. BENBAREK, H., MOUITHYS-MICKALAD A., DEBY-DUPONT, G., CAUDRON, I., DEBY C., LAMY M. & SERTEYN D. (1996a). Histamine stimulation of equine neutrophils: chemiluminescence and electron spin resonance study. VIII. Biennial Meeting of International Society for Free Radical Research, Barcelona, 309.
6. BENBAREK H., DEBY-DUPONT G., DEBY C., CAUDRON I., MATHY-H ARTET M., LAMY M. & SERTEYN D. (1996b). Experimental model for the study by chemiluminescence of the activation of isolated equine leucocytes. Research Veterinary Science 61, 59-64.
7. BENBAREK H., DEBY-DUPONT G., CAUDRON I., DEBY C. & SERTEYN D. (1997). Failure of lipopolysaccharides to directly trigger the chemiluminescence response of the isolated equine polymorphonuclear leucocytes. Veterinary Research Communication 21, 477-82.
8. BENBAREK H., DEBY-DUPONT G., CAUDRON I., GRÜLKE S., DEBY C., LAMY M. & SERTEYN D. (1998). Interactions between lipopolysaccharides and blood factors on the stimulation of equine polymorphonuclear neutrophils. Veterinary Immunology Immunopathology 64, 313-22.
9. BENBAREK H., MOUITHYS-MICKALAD A., DEBY-DUPONT G., DEBY C., GRÜLKE S., NEMMAR A., LAMY M. & SERTEYN D. (1999). Histamine stimulates equine polymorphonuclear neutrophils to produce reactive oxygen species as assessed by chemiluminescence and electron spin resonance studies. Inflammation Research (submitted)
10. CABANIS A., GRESSIER B., BRUNET C., DINE T., LUYCKX M., CAZIN M. & CAZIN J.C. (1996). Effect of the protein kinase inhibitor GF109203X on elastase release and respiratory burst of human neutrophils. General Pharmacology 27, 1409-14.
11. CARRERAS M.C., PARGAMENT G.A., CATZ S.D., PODEROSO J.J. & BOVERIS A. (1994). Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of neutrophils. FEBS Letters 341, 65-8.
12. COHEN H.J., CHOVANIEC M.E. & ELLIS S.E. (1980). Chlorpromazine inhibition of granulocyte superoxide production. Blood 56, 23-9.
13. GALEY F.D., BEASLEY V.R., SCHAEFFER D.J. & DAVIS L.E. (1989). Antagonism in isolated equine digital vessels of contraction induced by epinephrine in the presence of hydrocortisone and an aqueous extract of black walnut (JuglansNigra). Journal of Veterinary Pharmacology and Therapeuties 12, 411-20.
14. HENSON P.M., HENSON J.E., FITTSCHEN C., KIMANI G., BRATTON D.L., RICHES D.W.H. (1988). Phagocytic cells: degranulation and secretion. In Inflammation: Basic Principles and Clinical Correlates, eds. J.I. Gallin, I.M. Goldstein & M.D. Snyderman, pp. 363-90. New York: Raven Press Ltd.
15. HUNT R.J., BRANDON C.I. & MCCANN M.E. (1994). Effects of acetylpromazine, xylazine, and vertical load on digital arterial blood flow in horses. American Journal of Veterinary Research 55, 375.
16. KOPPENOL W.H., MORENO J.J., PRYOR W.A., ISCHIROPOULOS H. & BECKMAN J.S. (1992). Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chemical Research Toxicology 5, 834-42.
17. MUIR W.W. (1991). Standing chemical restraint in horses. Tranquilizers, sedatives, and analgesics. In Equine Anesthesia, Monitoring and Emergency Therapy, eds. W.W. Muir & J.A.E. Hubbel p. 247. USA: Mosby Year Book.
18. NEUGEBAUER E., LORENZ W., RIXEN D., STINNER B., SAUER S. & DIETZ W. (1996). Histamine release in sepsis: a prospective controlled, clinical study. Critical care medecine 24, 1670-7.
19. PYCOCK J.F., ALLEN W.E. & MORRIS T.H. (1987) Rapid single-step isolation of equine neutrophils on a discontinuous density gradient. Research in Veterinary Science 42, 411-2.
20. SERTEYN D., BENBAREK H., DEBY-DUPONT G., GRÜLKE S., CAUDRON, I. & LAMY M. (1997). Effects of acepromazine on the equine polymorphonuclear neutrophil activation induced by histamine or phorbol myristate acetate. Proceeding of the 6th International Congress of Veterinary Anaesthesiology 9, Greece p. 152.
21. VAN DER VLIET A., SMITH D., O'NEILL, C.A., KAUR H., PARCLEY -URMAR V., CROSS C.E. & HALLIWELL B. (1994). Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochemical Journal 303, 295-301.
22. VINCENT, P.C. (1986). Drug-induced aplastic anaemia and agranulocytosis; incidence and mechanisms. Drugs 31, 52-63.
23. WEISS S.J., LAMPERT M.B. & TEST S.T. (1983) Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 222, 625-8.
24. WINTERBOURN, C.C., VAN DEN BERG, J.J., RAITMAN, E. & KUYPERS F.A. (1992). Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Archives of Biochemistry and Biophysics 296, 547-55.